Sharlene is a Medical Scientist (BAppSc -Medical Laboratory Science) and managing director of a registered Australian education charity/NFO, Medical Cannabis Research Australia(MCRA) which has become the leading source in Australia for scientific education around medicinal cannabis. 

​

She is currently an Associate Researcher on a clinical trial in Perth, WA studying Cannabidiol for addiction and co-coordinating on a clinical trial for Musculoskeletal Origin Pain in Australia. She is committed to advocating for use and access to legal medical cannabis for patients in Australia as well as promoting more research to give clinicians the evidence they require to pursue research for patients in Australia.

​

Sharlene is currently engaged in her dream of building a hempcrete home in Wilyabrup, WA. She hopes to offer this house up as a showcase of how beautiful and sustainable, eco-friendly, and superior hempcrete can be. 

​

Dr. Reggie Gaudino oversees the genetics and scientific research division for Front Range Biosciences (FRB). Formerly the President at Steep Hill, the acquisition of Reggie and his team has significantly advanced FRB’s breeding program, resulting in additional unique and advantaged cannabis and hemp varieties.

Previously, Dr. Gaudino has served as a genetics researcher with 18 years of intellectual property experience in patent writing, management, and prosecution in fields as diverse as software and telecommunications to biotechnology and molecular genetics. Research from Dr. Gaudino has been peer-reviewed and published, leading to important new discoveries in the cannabis industry.

As an internationally recognized leader in the field of cannabis genetics, Dr. Gaudino has served as a patent agent at Sequenom, Inc., managed IP-based acquisitions for the Vortice Research Group, worked at four law firms focused on biotechnology, and has served as an advisor to multiple portfolio investment companies. Dr. Gaudino received his B.S. in Molecular Biology and Ph.D. in Molecular Genetics from the State University of New York at Buffalo and conducted four years of post-doctoral research at Washington University in St. Louis.

Maggie Fauver is a registered health information technician (RHIT) who began educating herself about the science behind cannabinoids in 2014. In 2015 Maggie joined Canna Care Docs, as Mid-Atlantic Operations Manager; launching the company’s mid-Atlantic expansion. There she worked closely with state regulators and physicians to educate and ensure smooth implementation of numerous states' medical cannabis programs.
 

Fauver has been a key presenter on cannabis at various speaking engagements where CME credits have been awarded, such as the Brain Injury Association & the American Association of Professional Coders annual state conferences. 

​

Dr. Mark L. Rabe is an integrative medicine specialist and leading figure in the evolving field of cannabinoid medicine. Dr. Rabe earned his medical degree at Northwestern University Medical School.  He is the Chief Executive Officer of Rabe Medical Solutions, LLC, a company that offers consulting and education to individuals seeking to attain optimal health and manage chronic medical conditions using natural methods. Dr. Rabe is also Director of Cannabinoid Program Development at PharmaCyte Biotech.

​

Previously, Dr. Rabe served as Chief Medical Officer of California’s largest network of physician-owned integrative care centers. There he hired and trained medical personnel, organized public educational symposia and media outreach, conducted research and supervised the recommendation of natural treatment options to over 100,000 patients in 20 medical clinics across California. Dr. Rabe graduated summa cum laude with a degree in biochemistry from Benedictine University, where he performed research in the area of cancer drug synthesis.

Leah Heise is passionate about bringing diversity to the industry and ensuring that it grows compliantly, ethically, and with employee and end user in mind. Since graduating from The Catholic University of America, Columbus School of Law in 1994, Leah has specialized in General Legal Practice to include:  Cannabis Licensing, Hemp licensing,  Cannabis Business Regulatory Compliance, Business Formation, Business Strategy & Growth to name a few. Since 2015, Leah has built and sold one plant touching company and assisted in scaling two other multi-state operators to initial Public Offering. She is regularly featured in print media, television, and radio as a cannabis industry expert in her field. 

Andrea has extensive experience in data analytics in the healthcare setting. She has led diverse projects including data capture, storage and forecast analysis. Designing and implementing key measurement reports for conveying metrics, monitoring service levels and attainments, identifying trends and performing root cause analysis.  Andrea previously served as Chief Operating Officer of CSC Events, LLC, the world's largest and most technical scientific cannabis event. The conferences pulls together cannabis industry experts, instrument manufacturers, testing labs, research scientists, medical practitioners and policy makers. 

In addition, Andrea earned a B.S. in Education from the University of Maryland and is Certified in CO2 Extraction. Her skills in data analytics, a deep understanding of cannabis and goals of education have made her an asset to Rylie’s team and the community the team serves. 

Paul founded Health House International which was granted the first medicinal cannabis import license in Australia. Paul brings a wealth of knowledge from his hands-on research in the U.S., UK, Canada, Australia and Israel. 

​

In 2019 Paul established Omega Assets, a startup currently producing hemp infused craft beer, spirits and hemp fed beef. Their flagship venue Valley Social in Perth's Swan Valley is set on 17 acres and has a 11,000m2 licensed area. 

​

Currently working as a consultant pharmacist with Australia's largest medical cannabis company Cannatrek.